EU regulator evaluating use of Pfizer's COVID-19 vaccine in young children


Reuters | Updated: 18-10-2021 19:48 IST | Created: 18-10-2021 19:46 IST
EU regulator evaluating use of Pfizer's COVID-19 vaccine in young children
Representative Image Image Credit: ANI

The European Union's medicines regulator said on Monday it has started evaluating the use of Pfizer Inc and BioNTech's COVID-19 vaccine in children between the ages of five and 11.

The European Medicines Agency said it will review data related to the vaccine, known as Comirnaty, including results from an ongoing clinical study involving young children.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback